Efficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues: A Prospective Study

Efficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues: A Prospective Study

Background: Tenofovir disoproxil (TDF) is a promising salvage therapy for patients with chronic hepatitis B (CHB) who failed regimens of other nucleoside analogues (NAs). In this study, we aimed to investigate the clinical efficacy and safety of TDF monotherapy in Chinese CHB patients with genotypi...

Full description

Bibliographic Details
Main Authors: Jing Zhou, Yue-Ying Liu, Jiang-Shan Lian, Li-Fang Pan, Jian-Le Yang, Jian-Rong Huang
Format: Article
Language:English
Published: Wolters Kluwer 2017-01-01
Series:Chinese Medical Journal
Subjects:
Drug Resistance; Hepatitis B; Tenofovir; Therapy; Safety
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2017;volume=130;issue=8;spage=914;epage=919;aulast=Zhou

Internet

http://www.cmj.org/article.asp?issn=0366-6999;year=2017;volume=130;issue=8;spage=914;epage=919;aulast=Zhou

Similar Items